Lymphadenectomy for Bladder Cancer: Indications and Controversies

Urologic Clinics of North America

Volumn 38, Issue 4, 2011, Pages 397-405

  Burkhard, Fiona C ^a   Roth, Beat ^a   Zehnder, Pascal ^a   Studer, Urs E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cystectomy; Invasive bladder cancer; Outcome; Pelvic lymph node dissection; Template

Indexed keywords

ANTINEOPLASTIC AGENT;

BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CYSTECTOMY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; OUTCOME ASSESSMENT; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TRANSURETHRAL RESECTION; TREATMENT INDICATION;

BIOPSY, NEEDLE; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPH NODES; MALE; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PELVIS; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 80955139424     PISSN: 00940143     EISSN: 1558318X     Source Type: Journal    
DOI: 10.1016/j.ucl.2011.07.011     Document Type: Review

References (50)

1. Vazina A., Dugi D., Shariat S.F., et al. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 2004, 171:1830-1834.
2. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001, 19:666-675.
3. Skinner D.G. Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol 1982, 128:34-36.
4. Madersbacher S., Hochreiter W., Burkhard F., et al. Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003, 21:690-696.
5. Leissner J., Hohenfellner R., Thuroff J.W., et al. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 2000, 85:817-823.
6. Herr H.W., Bochner B.H., Dalbagni G., et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002, 167:1295-1298.
7. Ficarra V., Dalpiaz O., Alrabi N., et al. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. BJU Int 2005, 95:786-790.
8. Kibel A.S., Dehdashti F., Katz M.D., et al. Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol 2009, 27:4314-4320.
9. Poulsen A.L., Horn T., Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 1998, 160:2015-2019. [discussion: 2020].
10. Leissner J., Ghoneim M.A., Abol-Enein H., et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 2004, 171:139-144.
11. Abdel-Latif M., Abol-Enein H., El-Baz M., et al. Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J Urol 2004, 172:85-89.
12. Shariat S.F., Palapattu G.S., Amiel G.E., et al. Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy. Urology 2006, 68:538-542.
13. Palapattu G.S., Shariat S.F., Karakiewicz P.I., et al. Cancer specific outcomes in patients with pT0 disease following radical cystectomy. J Urol 2006, 175:1645-1649. [discussion: 1649].
14. Whitmore W.F., Marshall V.F. Radical total cystectomy for cancer of the bladder: 230 consecutive cases five years later. J Urol 1962, 87:853-868.
15. Abol-Enein H., El-Baz M., Abd El-Hameed M.A., et al. Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study-a single center experience. J Urol 2004, 172:1818-1821.
16. Dangle P.P., Gong M.C., Bahnson R.R., et al. How do commonly performed lymphadenectomy templates influence bladder cancer nodal stage?. J Urol 2010, 183:499-503.
17. Roth B., Wissmeyer M.P., Zehnder P., et al. A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol 2010, 57:205-211.
18. Roth B., Zehnder P., Birkhauser F.D., et al. Does the lymphatic drainage pattern of the lateral bladder wall make a bilateral pelvic lymph node dissection (PLND) unnecessary in strictly laterally localized invasive bladder cancer? Results of a multimodality mappping study. J Urol 2011, 185:e562.
19. Liedberg F., Chebil G., Davidsson T., et al. Intraoperative sentinel node detection improves nodal staging in invasive bladder cancer. J Urol 2006, 175:84-88. [discussion: 8-9].
20. Knapp D.W., Adams L.G., Degrand A.M., et al. Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light. Eur Urol 2007, 52:1700-1708.
21. Mills R.D., Turner W.H., Fleischmann A., et al. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol 2001, 166:19-23.
22. Kessler T.M., Burkhard F.C., Studer U.E. Clinical indications and outcomes with nerve-sparing cystectomy in patients with bladder cancer. Urol Clin North Am 2005, 32:165-175.
23. Stein J.P., Penson D.F., Cai J., et al. Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol 2007, 177:876-881. [discussion: 881-2].
24. Fang A.C., Ahmad A.E., Whitson J.M., et al. Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer. Cancer 2010, 116:1901-1908.
25. Weingartner K., Ramaswamy A., Bittinger A., et al. Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J Urol 1996, 156:1969-1971.
26. Fleischmann A., Thalmann G.N., Markwalder R., et al. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol 2005, 23:2358-2365.
27. Kerr W.S., Colby F.H. Pelvic lymphadenectomy and total cystectomy in the treatment of carcinoma of the bladder. J Urol 1950, 63:842-851.
28. Smith J.A., Whitmore W.F. Regional lymph node metastasis from bladder cancer. J Urol 1981, 126:591-593.
29. Pagano F., Bassi P., Galetti T.P., et al. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 1991, 145:45-50.
30. Vieweg J., Gschwend J.E., Herr H.W., et al. Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol 1999, 161:449-454.
31. Kassouf W., Agarwal P.K., Herr H.W., et al. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol 2008, 26:121-126.
32. Ghoneim M.A., el-Mekresh M.M., el-Baz M.A., et al. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. J Urol 1997, 158:393-399.
33. Dhar N.B., Klein E.A., Reuther A.M., et al. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 2008, 179:873-878. [discussion: 878].
34. Zehnder P., Studer U., Skinner E., et al. Extended lymph node dissecton for patients undergoing radical cystectomy for cancer: how high?. J Urol 2011, 185:e563.
35. Dorin RP, Eisenberg ME, Cai J. Proximal extent of lymph node (LN) metastasis and other independent prognositc indicators in 162 LN positive patients undergoing radical cystectomy with extended LN dissection for bladder cancer. In: 2010 ASCo Genitourinary Cancers Symposium. San Francisco (CA); March 5-7, 2010. p. 139 [abstract nr.: 299].
36. Herr H.W. Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 2003, 61:105-108.
37. Herr H., Lee C., Chang S., et al. Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. J Urol 2004, 171:1823-1828. [discussion: 1827-8].
38. Retz M., Lehmann J., Szysnik C., et al. Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCR. Eur Urol 2004, 45:314-319.
39. Marin-Aguilera M., Mengual L., Burset M., et al. Molecular lymph node staging in bladder urothelial carcinoma: impact on survival. Eur Urol 2008, 54:1363-1372.
40. Autenrieth M., Nawroth R., Semmlack S., et al. Urologe A 2008, 47:1157-1161. [in German].
41. Lerner S.P., Skinner D.G., Lieskovsky G., et al. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol 1993, 149:758-764. [discussion: 764-5].
42. Herr H.W. Superiority of ratio based lymph node staging for bladder cancer. J Urol 2003, 169:943-945.
43. Stein J.P., Cai J., Groshen S., et al. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 2003, 170:35-41.
44. Wiesner C., Salzer A., Thomas C., et al. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density. BJU Int 2009, 104:331-335.
45. Park J., Kim S., Jeong I.G., et al. Does the greater number of lymph nodes removed during standard lymph node dissection predict better patient survival following radical cystectomy?. World J Urol 2011, 29(4):443-449.
46. Herr H.W., Donat S.M. Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. J Urol 2001, 165:62-64. [discussion: 64].
47. Zehnder P., Studer U.E., Skinner E.C., et al. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol 2011, 186(4):1261-1268.
48. Grossman H.B., Natale R.B., Tangen C.M., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003, 349:859-866.
49. Herr H.W., Faulkner J.R., Grossman H.B., et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 2004, 22:2781-2789.
50. Hautmann R.E., Gschwend J.E., de Petriconi R.C., et al. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol 2006, 176:486-492. [discussion: 491-2].